iBio
IBIO
#9671
Rank
โ‚น5.47 B
Marketcap
โ‚น243.50
Share price
14.89%
Change (1 day)
13.92%
Change (1 year)

Market capitalization of iBio (IBIO)

Market cap: โ‚น5.47 Billion

As of January 2026 iBio has a market cap of โ‚น5.47 Billion. This makes iBio the world's 9671th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of iBio from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น5.47 B43.52%
2025โ‚น3.81 B98.4%
2024โ‚น1.92 B740.93%
2023โ‚น0.22 B-30.93%
2022โ‚น0.33 B-96.28%
2021โ‚น8.90 B-45.23%
2020โ‚น16.26 B1578.35%
2019โ‚น0.96 B-2.36%
2018โ‚น0.99 B-23.9%
2017โ‚น1.30 B-45.48%
2016โ‚น2.39 B-16.88%
2015โ‚น2.87 B-7.92%
2014โ‚น3.12 B134.31%
2013โ‚น1.33 B-17.75%
2012โ‚น1.62 B14.05%
2011โ‚น1.42 B-68.91%
2010โ‚น4.57 B287.29%
2009โ‚น1.18 B897.3%
2008โ‚น0.11 B

End of Day market cap according to different sources

On Jan 11th, 2026 the market cap of iBio was reported to be:

โ‚น5.47 Billion
by Nasdaq info icon info icon
โ‚น5.47 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Genocea Biosciences
GNCA
โ‚น0.53 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น62.35 B 1,038.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น44.410 T 810,951.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
โ‚น72.84 B 1,230.40%๐Ÿ‡บ๐Ÿ‡ธ USA